Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul:29:226-271.
doi: 10.1016/j.jtos.2023.04.003. Epub 2023 Apr 25.

TFOS Lifestyle: Impact of nutrition on the ocular surface

Affiliations

TFOS Lifestyle: Impact of nutrition on the ocular surface

Maria Markoulli et al. Ocul Surf. 2023 Jul.

Abstract

Nutrients, required by human bodies to perform life-sustaining functions, are obtained from the diet. They are broadly classified into macronutrients (carbohydrates, lipids, and proteins), micronutrients (vitamins and minerals) and water. All nutrients serve as a source of energy, provide structural support to the body and/or regulate the chemical processes of the body. Food and drinks also consist of non-nutrients that may be beneficial (e.g., antioxidants) or harmful (e.g., dyes or preservatives added to processed foods) to the body and the ocular surface. There is also a complex interplay between systemic disorders and an individual's nutritional status. Changes in the gut microbiome may lead to alterations at the ocular surface. Poor nutrition may exacerbate select systemic conditions. Similarly, certain systemic conditions may affect the uptake, processing and distribution of nutrients by the body. These disorders may lead to deficiencies in micro- and macro-nutrients that are important in maintaining ocular surface health. Medications used to treat these conditions may also cause ocular surface changes. The prevalence of nutrition-related chronic diseases is climbing worldwide. This report sought to review the evidence supporting the impact of nutrition on the ocular surface, either directly or as a consequence of the chronic diseases that result. To address a key question, a systematic review investigated the effects of intentional food restriction on ocular surface health; of the 25 included studies, most investigated Ramadan fasting (56%), followed by bariatric surgery (16%), anorexia nervosa (16%), but none were judged to be of high quality, with no randomized-controlled trials.

Keywords: Diabetes; Diet; Dry eye disease; Food restriction; Gut microbiome; Keratitis; Lifestyle; Mediterranean diet; Ocular surface; Systematic review.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Maria Markoulli: Alcon (F), CooperVision (F). Sumaya Ahmad: None. Jayashree Arcot: None. Reiko Arita: (P), Alcon (F), Novartis (F), Senju Pharmaceutical (F), Santen (F), Rohto Pharmaceutical (F), Johnson & Johnson (F), Lumenis (F), Inami (F), Topcon (C). Jose M Benitez-del-Castillo: Alcon (C), Allergan (C), Angelini (C), Brill Farma (C), Esteve (F), GSK (C), Horus (C), Lumenis (F), Novartis (C), Santen (F), Thea (F). Barbara Caffery: Azura (F), Santen (C), VTI (F), Dompe (C). Laura Downie: Alcon Laboratories (F), Azura Ophthalmics (F), CooperVision (F), Kedalion Therapeutics (F), Medmont International (F), Novartis (F), Seqirus (F). Katie Edwards: None. Judith Flanagan: None. Marc Labetoulle: Alcon (F), Allergan (F), Baush & Lomb (F), DMG (F), Dompe (F), GSK (F), Horus (F), MSD (F), Novartis (F), PHE (F), Quantel (F), Santen (F), Shire (F), Sifi (F), Topivert (F), Théa (F). Stuti Misra: None. Malgorzata Mrugacz: None. John Sheppard: None. Sumeer Singh: None. Jelle Vehof: Alcon (C), Tramedico (C), Santen (C), Théa Pharma (C), Horus Pharma (C). Piera Versura: None. Mark Willcox: Alcon (F), Allergan (F), CooperVision (F), Johnson and Johnson Vision (F), Ophtecs (C, F). Jillian Ziemanski: None. James Wolffsohn: AOS (C), Aston Vision Sciences (S), Bausch & Lomb (C), Alcon (C,F), Allergan (F), CooperVision (C,F), CSIDryEye (C), Eyoto (S), Johnson & Johnson Vision (F), Rayner (F), M2C Pharmaceuticals (C,F), Medmont (C), Novartis (C,F), NuVision (C,F), Santen (C), Scope Ophthalmics (C,F), Théa (C,F), Topcon (F), The Eye Doctor (F), Wolffsohn Research Limited (S).

Publication types

LinkOut - more resources